Seborrheic Dermatitis
📧 Sign up to get email alerts when something new happens for Seborrheic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-02-23Clinical Trial Update: STUDY TO ASSESS THE LONG-TERM SAFETY OF EXTINA (KETOCONAZOLE) FOAM, 2% [Phase 4]
This Phase 4 trial update reports the long-term safety results of Extina (ketoconazole) 2% foam for seborrheic dermatitis.
-
CLINICAL_TRIALS trial_result · 2011-10-12Clinical Trial Update: Efficacy and Safety of Low-dose Oral Isotretinoin for Seborrhea [Phase 4]
A Phase 4 clinical trial update assesses the efficacy and safety of low-dose oral isotretinoin for seborrhea and seborrheic dermatitis, incl…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage [Phase 2]
Phase 2 clinical trial update evaluating Topically Dissolved Oxygen (TDO) to reduce signs of photodamage. The study includes rosacea, acne v…
-
CLINICAL_TRIALS trial_result · 2010-06-04Clinical Trial Update: K301 for the Treatment of Seborrhoeic Eczema (SE) of the Scalp [Phase 3]
Phase 3 trial update indicates completion of the K301 study for seborrheic dermatitis of the scalp.
-
CLINICAL_TRIALS trial_result · 2009-12-02Clinical Trial Update: Evaluation of the Effectiveness of a Product Containing Topical Hydrocortisone in the Treatment of Seborrheic Dermatitis of the Face
A clinical trial update evaluating the effectiveness of a product containing topical hydrocortisone for facial seborrheic dermatitis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-11-11Clinical Trial Update: Efficacy and Tolerability of Prednisolone Acetate 0.5% Cream Versus Betamethasone Valerate 0.1% Cream in Cortisosensitive Dermatosis [Phase 3]
Phase 3 trial comparing prednisolone acetate 0.5% cream with betamethasone valerate 0.1% cream to assess efficacy and tolerability in cortic…
-
CLINICAL_TRIALS trial_result · 2008-10-07Clinical Trial Update: Botulinum Toxin for Treatment of Seborrhic Dermatitis in Parkinsonian Patients [Phase 1]
Phase 1 trial investigating botulinum toxin for seborrheic dermatitis in Parkinsonian patients; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2008-06-03Clinical Trial Update: Efficacy and Safety of ASF1057 in the Treatment of Seborrhoeic Dermatitis [Phase 3]
A Phase 3 trial evaluating ASF1057 for seborrheic dermatitis has completed, assessing efficacy and safety.